• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Annovis Bio(ANVS.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec3
Annovis Bio to Present Third-Stage Data on Parkinson's Dementia at Annual Meeting
13:01
Nov13
Annovis Bio released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -1.0099
04:00
Annovis Bio released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3699 (forecast USD -0.3766)
04:00
Nov7
Maxim Group Analyst Jason McCarthy Maintains Buy Rating on Annovis Bio
18:12
Oct14
Annovis Bio Inc. Issues Ordinary Shares to Raise $6 Million
21:20
Oct9
Annovis Bio Inc.'s Drug Buntanetap Shows Positive Biomarker Data in Alzheimer's Research
11:30

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.263 M, EPS -0.3699

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.22 M, EPS -0.32

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.537 M, EPS -0.32

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More